急性肾损伤、谵妄与危重症患者结局的关联:系统评价与Meta分析
该研究系统检索MEDLINE、Embase、CINAHL、Scopus、Web of Science和Cochrane Library(2000年1月至2025年1月),纳入18项观察性研究、共158,694例ICU患者。急性肾损伤按各研究采用的当代定义中的血清肌酐或尿量标准判定,主要结局为合并急性肾损伤的危重症患者中谵妄的发生比例。合并急性肾损伤的患者中谵妄的合并比例为32%(95%CI 18-47%);与未发生谵妄的急性肾损伤患者相比,发生谵妄者死亡率更高(RR 2.36,95%CI 1.61-3.47,中等确定性)、肾脏替代治疗使用更多(RR 3.12,95%CI 1.89-5.15,中等确定性)、ICU住院时间更长(WMD 3.54天,95%CI 1.20-5.87天,中等确定性)及住院时间更长(WMD 4.78天,95%CI 3.48-6.09天,中等确定性)。
要点
- 合并急性肾损伤的危重症患者中,谵妄的合并发生比例为32%(95%CI 18-47%)。
- 急性肾损伤患者发生谵妄与死亡率升高相关(RR 2.36,95%CI 1.61-3.47,中等确定性)。
- 急性肾损伤患者发生谵妄与肾脏替代治疗使用增加相关(RR 3.12,95%CI 1.89-5.15,中等确定性)。
- 急性肾损伤患者发生谵妄与ICU住院时间延长3.54天(95%CI 1.20-5.87天)及住院时间延长4.78天(95%CI 3.48-6.09天)相关,均为中等确定性。
- 证据来自18项观察性研究、共158,694例患者,总体研究质量为中等。
适用人群与场景
- ICU收治的危重症患者,研究纳入同时报告急性肾损伤与谵妄的观察性研究。
诊断标准与关键阈值
- 急性肾损伤按各研究采用的当代定义中的血清肌酐或尿量标准判定。
研究设计与关键结果
- 研究类型为系统评价与Meta分析,纳入18项观察性研究,共158,694例患者,总体研究质量为中等。
- 合并急性肾损伤的危重症患者中谵妄的合并发生比例为32%(95%CI 18-47%)。
- 与未发生谵妄的急性肾损伤患者相比,发生谵妄者死亡率更高(RR 2.36,95%CI 1.61-3.47,中等确定性)。
- 与未发生谵妄的急性肾损伤患者相比,发生谵妄者肾脏替代治疗使用更多(RR 3.12,95%CI 1.89-5.15,中等确定性)。
- 与未发生谵妄的急性肾损伤患者相比,发生谵妄者ICU住院时间更长(WMD 3.54天,95%CI 1.20-5.87天,中等确定性)。
- 与未发生谵妄的急性肾损伤患者相比,发生谵妄者住院时间更长(WMD 4.78天,95%CI 3.48-6.09天,中等确定性)。
证据类型、等级与局限
- 证据类型为系统评价与Meta分析,纳入18项观察性研究;采用GRADE方法评估证据确定性,主要结局及关键次要结局均为中等确定性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,谵妄在合并急性肾损伤的危重症患者中常见,且与更差的结局和更高的医疗资源使用相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute kidney injury (AKI) and delirium are common complications of critical illness. However, relatively few studies have evaluated their relationship. We conducted a systematic synthesis and meta-analysis of existing evidence to clarify this association in critically ill patients.
DATA SOURCES: A comprehensive search was conducted across MEDLINE, Embase, CINAHL, Scopus, Web of Science, and Cochrane Library for publications reporting both AKI and delirium in ICUs patients from January 2000 to January 2025.
STUDY SELECTION: AKI was defined according to serum creatinine or urine output criteria based on the contemporary definitions used in the individual studies. The primary outcome was the proportion of critically ill patients with AKI who developed delirium. Secondary outcomes included mortality and health service utilization.
DATA EXTRACTION: Pooled meta-analyses were summarized as effect sizes in proportions, risk ratios (RRs), odds ratios, or weighted mean differences (WMDs) using a random-effects model. The certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation approach.
DATA SYNTHESIS: Eighteen observational studies comprising 158,694 patients were included. Overall study quality was moderate. The pooled proportion of delirium among patients with AKI was 32% (95% CI, 18-47%). Delirium was associated with higher mortality (RR, 2.36; 95% CI, 1.61-3.47; moderate certainty), greater renal replacement therapy use (RR, 3.12; 95% CI, 1.89-5.15; moderate certainty), longer ICU stays (WMD, 3.54 d; 95% CI, 1.20-5.87 d; moderate certainty), and longer hospital stays (WMD, 4.78 d; 95% CI, 3.48-6.09 d; moderate certainty) compared with patients with AKI not experiencing delirium.
CONCLUSIONS: Delirium is common among critically ill patients with AKI and is associated with worse outcomes and greater health resource use.
参考来源
- Kusirisin P, Corsaro A, Kung JY, et al. Association Between Acute Kidney Injury, Delirium, and Outcomes in Patients With Critical Illness: A Systematic Review and Meta-Analysis. Crit Care Med. 2025. PMID: 41405369. doi:10.1097/CCM.0000000000006997
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。